237 related articles for article (PubMed ID: 37569532)
1. Total Neoadjuvant Treatment for Locally Advanced Rectal Cancer Patients: Where Do We Stand?
Daprà V; Airoldi M; Bartolini M; Fazio R; Mondello G; Tronconi MC; Prete MG; D'Agostino G; Foppa C; Spinelli A; Puccini A; Santoro A
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569532
[TBL] [Abstract][Full Text] [Related]
2. A contemporary assessment of total neoadjuvant therapy (TNT) protocols for locally advanced rectal cancer: adoption and expert perspectives at German Cancer Society (DKG)-certified colorectal cancer centers.
Langheinrich M; Paasch C; Mantke R; Weber K; Benz S; Kersting S
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12591-12596. PubMed ID: 37438538
[TBL] [Abstract][Full Text] [Related]
3. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
[No Abstract] [Full Text] [Related]
4. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer].
Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307
[No Abstract] [Full Text] [Related]
5. Implications of recent neoadjuvant clinical trials on the future practice of radiotherapy in locally advanced rectal cancer.
Kang MK
World J Gastroenterol; 2023 Feb; 29(6):1011-1025. PubMed ID: 36844136
[TBL] [Abstract][Full Text] [Related]
6. Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer.
Cercek A; Roxburgh CSD; Strombom P; Smith JJ; Temple LKF; Nash GM; Guillem JG; Paty PB; Yaeger R; Stadler ZK; Seier K; Gonen M; Segal NH; Reidy DL; Varghese A; Shia J; Vakiani E; Wu AJ; Crane CH; Gollub MJ; Garcia-Aguilar J; Saltz LB; Weiser MR
JAMA Oncol; 2018 Jun; 4(6):e180071. PubMed ID: 29566109
[TBL] [Abstract][Full Text] [Related]
7. Locally advanced rectal cancer receiving total neoadjuvant therapy combined with nivolumab: a case report and literature review.
Mori R; Uemura M; Sekido Y; Hata T; Ogino T; Takahashi H; Miyoshi N; Mizushima T; Doki Y; Eguchi H
World J Surg Oncol; 2022 May; 20(1):166. PubMed ID: 35619103
[TBL] [Abstract][Full Text] [Related]
8. The Evolving Neoadjuvant Treatment Paradigm for Patients with Locoregional mismatch Repair Proficient Rectal Cancer.
Bhudia J; Glynne-Jones R
Curr Treat Options Oncol; 2022 Apr; 23(4):453-473. PubMed ID: 35312962
[TBL] [Abstract][Full Text] [Related]
9. Evolving Treatment Paradigm in the Treatment of Locally Advanced Rectal Cancer.
Smith CA; Kachnic LA
J Natl Compr Canc Netw; 2018 Jul; 16(7):909-915. PubMed ID: 30006431
[TBL] [Abstract][Full Text] [Related]
10. Total neoadjuvant treatment to increase the clinical complete response rate for distal locally advanced rectal cancer (TESS): A study protocol of a prospective, open-label, multicenter, single-arm, phase 2 trial.
Liu S; Wang X; Zhuang Y; Bai S; Wu X; Ye Y; Luo H; Yu H; Wang Q; Chang H; Zeng Z; Cai P; Pan Z; Gao Y; Chen G; Xiao W
Cancer Med; 2023 Jun; 12(12):13352-13360. PubMed ID: 37156624
[TBL] [Abstract][Full Text] [Related]
11. Total neoadjuvant therapy for the treatment of locally advanced rectal cancer: a systematic minireview.
Guida AM; Sensi B; Formica V; D'Angelillo RM; Roselli M; Del Vecchio Blanco G; Rossi P; Capolupo GT; Caricato M; Sica GS
Biol Direct; 2022 Jun; 17(1):16. PubMed ID: 35698084
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy and safety of total neoadjuvant therapy versus neoadjuvant chemoradiotherapy in the treatment of locally advanced rectal cancer: a meta-analysis].
Zhang YQ; Sun KG; Lu JY; Ma J; Yao N; Qin ZH; Yao YH
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jun; 25(6):531-538. PubMed ID: 35754218
[No Abstract] [Full Text] [Related]
13. Trends in adoption of total neoadjuvant therapy for locally advanced rectal cancer.
Unuvar M; Blansfield J; Wang S; Hoffman RL
Am J Surg; 2024 Jan; 227():229-236. PubMed ID: 37923661
[TBL] [Abstract][Full Text] [Related]
14. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH
BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356
[TBL] [Abstract][Full Text] [Related]
15. Tailored total neoadjuvant therapy for locally advanced rectal cancer: One size may not fit for all!
Ozer L; Yildiz I; Bayoglu V; Bozkurt M; Esen E; Remzi FH; Gogenur I; Aytac E
Colorectal Dis; 2021 Jul; 23(7):1662-1669. PubMed ID: 33829626
[TBL] [Abstract][Full Text] [Related]
16. [Short-term outcome of programmed cell death protein1 (PD-1) antibody combined with total neoadjuvant chemoradiotherapy in the treatment of locally advanced middle-low rectal cancer with high risk factors].
Li YJ; Zhang L; Dong QS; Cai Y; Zhang YZ; Wang L; Yao YF; Zhang XY; Li ZW; Li YH; Sun YS; Wang WH; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Nov; 24(11):998-1007. PubMed ID: 34823301
[No Abstract] [Full Text] [Related]
17. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
[No Abstract] [Full Text] [Related]
18. The role of total neoadjuvant therapy in locally advanced rectal cancer: a survey of specialists attending the All-Ireland Colorectal Cancer Conference 2022 including lead investigators of OPRA, PRODIGE-23 and RAPIDO.
O'Brien T; Hospers G; Conroy T; Lenz HJ; Smith JJ; Andrews E; O'Neill B; Leonard G
Ir J Med Sci; 2024 Jun; 193(3):1183-1190. PubMed ID: 38141097
[TBL] [Abstract][Full Text] [Related]
19. Total neoadjuvant therapy for rectal cancer: An emerging option.
Ludmir EB; Palta M; Willett CG; Czito BG
Cancer; 2017 May; 123(9):1497-1506. PubMed ID: 28295220
[TBL] [Abstract][Full Text] [Related]
20. Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management.
Smith JJ; Chow OS; Gollub MJ; Nash GM; Temple LK; Weiser MR; Guillem JG; Paty PB; Avila K; Garcia-Aguilar J;
BMC Cancer; 2015 Oct; 15():767. PubMed ID: 26497495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
